76144-15-5

Basic information

• Product Name: Pentanedioic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl phenylmethyl ester, (3R)-
• CAS NO: 76144-15-5
• Molecular Formula: C18H25NO6
• Molecular Weight: 351.4
• Mol File: 76144-15-5.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: Pentanedioic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl phenylmethyl ester, (3R)-(CAS DataBase Reference)
• NIST Chemistry Reference: Pentanedioic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl phenylmethyl ester, (3R)-(76144-15-5)
• EPA Substance Registry System: Pentanedioic acid, 3-[[(1,1-dimethylethoxy)carbonyl]amino]-, methyl phenylmethyl ester, (3R)-(76144-15-5)

Safety Data

• Hazardous Substances Data: 76144-15-5(Hazardous Substances Data)

Upstream product

• 186581-53-3 diazomethane 
• 67-56-1 methanol 
• 7536-58-5 BOC-L-aspartic acid 4-benzyl ester 
• 18107-18-1 diazomethyl-trimethyl-silane 

Downstream Products

• 82290-94-6 (R)-4-3'-diazo-3'-p-nitrobenzyloxycarbonyl-2'-oxopropyl-2-azetidinone 
• 82336-07-0 p-nitrobenzyl (3R,5R)-1-carba-2-oxopenam-3-carboxylate 
• 87727-17-1 (R)-4-3'-p-nitrobenzyloxycarbonyl-2'-oxopropyl-2-azetidinone 
• 76144-20-2 (4R)-4-<3-(Benzyloxycarbonyl)-2-oxopropyl>azetidin-2-one 
• 103841-73-2 p-nitrobenzyl (5S,2'R)-2-2'-p-nitrobenzyloxycarbonyl-2'-p-nitrobenzyloxycarbonylaminoethylthio-1-carba-2-penem-3-carboxylate 
• 103841-71-0 (R)-4-3'-diphenylmethyloxycarbonyl-3'-p-nitrobenzyloxycarbonyl-2'-oxopropyl-2-azetidinone 
• 103841-62-9 (R)-3-Benzylamino-4-chlorocarbonyl-butyric acid methyl ester; hydrochloride 
• 76144-21-3 (R)-4-3'-benzyloxycarbonyl-3'-diazo-2'-oxopropyl-2-azetidinone 
• 76144-18-8 (S)-N-(diphenylmethyloxycarbonyl)methyl-2-azetidinone 
• 76189-53-2 benzyl (3R,5R)-1-carba-2-oxopenam-3-carboxylate 
• 80974-44-3 (S)-N-benzyl-4-carboxymethyl-2-azetidinone 
• 76144-17-7 (4R) N-Benzyl-4-methoxycarbonylmethyl-azetidin-2-one 
• 76144-16-6 5-methyl 1-hydrogen (S)-3-benzylaminoglutarate 

Relevant articles and documents

NOVEL DISUBSTITUTED 1, 2, 4-TRIAZINE COMPOUND

This invention provides a novel disubstituted 1,2,4-triazine compound or a pharmaceutically acceptable salt thereof, which has an aldosterone synthetase inhibitory activity and is useful for preventing and/or treating various diseases or conditions associated with aldosterone; a method for preparing it; use of it; as well as a pharmaceutical composition comprising it as an active ingredient. A compound of the general formula [I]: wherein RA is, for example, a group of the following formula (A-1): wherein ring A1 is, for example, a cycloalkyl group which may be substituted, and RB is, for example, a monocyclic cycloalkyl group, or a pharmaceutically acceptable salt thereof.